Kinsale Capital Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,626
Closed -$3.46M 38
2024
Q4
$3.46M Buy
13,626
+1,849
+16% +$496K 0.93% 34
2024
Q3
$3.73M Buy
11,777
+2,062
+21% +$734K 1.1% 34
2024
Q2
$3.63M Buy
9,715
+2,231
+30% +$753K 1.26% 31
2024
Q1
$2.59M Buy
7,484
+2,240
+43% +$849K 1.03% 35
2023
Q4
$2.4M Buy
5,244
+1,249
+31% +$616K 1.19% 29
2023
Q3
$1.94M Buy
3,995
+1,009
+34% +$474K 1.1% 23
2023
Q2
$1.33M Buy
2,986
+1,009
+51% +$508K 0.81% 28
2023
Q1
$960K Buy
1,977
+1,177
+147% +$582K 0.7% 13
2022
Q4
$410K Buy
+800
New +$420K 0.36% 8

Other funds holding HUM

Kinsale Capital Group's HUM Position: Q1 2025 in Review

Kinsale Capital Group sold out of Humana (HUM) in Q1 2025, closing a stake of 13,626 shares — an estimated $3.46M sold.

Kinsale Capital Group first reported a position in HUM in Q4 2022 and held it in 9 quarters. The position peaked at $3.73M in Q3 2024. 901 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Kinsale Capital Group reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Kinsale Capital Group sold 13,626 Humana shares in Q1 2025, an estimated $3.46M.
  • Kinsale Capital Group first reported a position in Humana in Q4 2022 and held it in 9 quarters.
  • Kinsale Capital Group's Humana position peaked at $3.73M in Q3 2024.
  • 901 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Kinsale Capital Group's 13F filing for Q1 2025, filed 7 May 2025.